{"id":2311,"date":"2010-11-24T15:19:00","date_gmt":"2010-11-24T15:19:00","guid":{"rendered":"https:\/\/www2.thestockmarketwatch.com\/stock-market-news\/jj-recalling-benadryl-and-motrin\/2307\/"},"modified":"2010-11-24T15:19:00","modified_gmt":"2010-11-24T15:19:00","slug":"jj-recalling-benadryl-and-motrin","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/jj-recalling-benadryl-and-motrin\/2311\/","title":{"rendered":"J&J Recalling Benadryl and Motrin"},"content":{"rendered":"

<\/a>Johnson & Johnson<\/strong> (NYSE<\/a>:JNJ<\/strong><\/a>) is recalling two of its popular drugs from the market citing insufficiencies in the manufacturing process. The recall is being made for more than 4 million packages of junior strength Motrin and children\u2019s Benadryl Allergy tablets.<\/p>\n

<\/span><\/p>\n

The recall is only for the current stock which has only reached wholesalers and retailers. Hence the customers who have the medicine already purchased a week before can safely use them. The recalled medicines do not have any heath safety concerns. There was no immediate effect on the shares of Johnson & Johnson<\/strong> (NYSE:JNJ<\/strong><\/a>) due to these recalls.<\/p>\n

Related posts:<\/p>\n

    \n
  1. Finding The Source of HIV<\/a><\/li>\n
  2. Theraputic Discovery Grant Awarded to Affymax<\/a><\/li>\n
  3. GSK Gets Green Light For Lupus<\/a><\/li>\n
  4. Wal-Mart\u2019s Success with Prescription Plan<\/a><\/li>\n
  5. Jane Fonda Confirms breast Cancer<\/a><\/li>\n<\/ol>\n
    « Return to Stock Market News<\/a> « <\/div>\n
    \n
    \n